IGIV prophylaxis therapy for CMV in renal transplant recipients.
Mendoza
M
M
D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation
D016756:Immunoglobulins, Intravenous